347 related articles for article (PubMed ID: 26664449)
1. Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development.
Sharma C; Sadek B; Goyal SN; Sinha S; Kamal MA; Ojha S
Evid Based Complement Alternat Med; 2015; 2015():238482. PubMed ID: 26664449
[TBL] [Abstract][Full Text] [Related]
2. Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects.
Patil KR; Goyal SN; Sharma C; Patil CR; Ojha S
Curr Med Chem; 2015; 22(30):3472-501. PubMed ID: 26179998
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
4. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pharmacology of Phytocannabinoids.
Turner SE; Williams CM; Iversen L; Whalley BJ
Prog Chem Org Nat Prod; 2017; 103():61-101. PubMed ID: 28120231
[TBL] [Abstract][Full Text] [Related]
7. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
8. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
De Petrocellis L; Di Marzo V
J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
[TBL] [Abstract][Full Text] [Related]
9. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
10. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
13. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products.
An D; Peigneur S; Hendrickx LA; Tytgat J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709050
[TBL] [Abstract][Full Text] [Related]
14. The neurobiology and evolution of cannabinoid signalling.
Elphick MR; Egertová M
Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
[TBL] [Abstract][Full Text] [Related]
15. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses.
Walsh KB; McKinney AE; Holmes AE
Front Pharmacol; 2021; 12():777804. PubMed ID: 34916950
[TBL] [Abstract][Full Text] [Related]
16. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanism and Cannabinoid Pharmacology.
Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
[TBL] [Abstract][Full Text] [Related]
18. Terpenoids, Cannabimimetic Ligands, beyond the
Gonçalves ECD; Baldasso GM; Bicca MA; Paes RS; Capasso R; Dutra RC
Molecules; 2020 Mar; 25(7):. PubMed ID: 32235333
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
